Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | McCulloch KevinSee Remarks | Option exercise | M | $15.76 4 sh | Mar 16, 2026 |
| 5 | Asmerom AmineChief Accounting Officer | Grant or award | A | — 75.0K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 5 | Chewning Eric D.EVP, Maritime Sys & Corp STR | Grant or award | A | — 7 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 5 | Tanious Jubran N.President & COO | Grant or award | A | — 16.4K sh | Mar 16, 2026 traded Mar 13, 2026 |
| 5 | Hughes Edmond E. Jr.Ex VP & Chief HR Officer | Grant or award | A | — 7 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 3 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 6,348 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 3 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 2,985 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 3 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 1,754 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 2 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $216K 2,985 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 2 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $121K 4,125 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 1 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $84K 3,079 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 1 | Steves SeanSr VP & COO of SW Ops | Open-market sale · 10b5-1 plan | SELL | $17K 197 sh | Mar 16, 2026 traded Mar 16, 2026 |
| 0 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | $49K 1,754 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $59K 4,167 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 3,542 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 4,167 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $36K 3,542 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $7,038 253 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 0 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 8,456 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $6,856 6,348 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 56 | Nielson Brandon R.Director | NAKeystone Private Income Fund Open-market purchase | BUY | $10.00M 101.5K sh | Mar 13, 2026 traded Mar 1, 2026 |
| 50 | Dorosh DmitriyPrincipal Accounting Officer | Open-market sale | SELL | $1.14M 2,509 sh | Mar 13, 2026 traded Mar 13, 2026 |
| 48 | Lockridge MatthewHead, U.S. Value Inv. | Open-market sale | SELL | $87K 5,379 sh | Mar 13, 2026 traded Feb 23, 2026 |
| 48 | Helfert AdrianCIO, Multi-Asset Inv. | Open-market sale | SELL | $175K 10.8K sh | Mar 13, 2026 traded Feb 23, 2026 |
| 47 | Dorosh DmitriyPrincipal Accounting Officer | Open-market sale | SELL | $272K 600 sh | Mar 13, 2026 traded Mar 13, 2026 |
| 45 | Coldrake RobertChief Financial Officer | Open-market sale | SELL | $491K 4,613 sh | Mar 13, 2026 traded Mar 11, 2026 |
| 45 | Linton David OHead of Distribution | Open-market sale | SELL | $43K 2,654 sh | Mar 13, 2026 traded Feb 23, 2026 |
| 45 | Mujica Hernan E.CHIEF TECHNOLOGY OFFICER | Open-market sale | SELL | $850K 5,000 sh | Mar 13, 2026 traded Mar 13, 2026 |
| 44 | Frazier SpencerEVP of Sales and Marketing | Open-market purchase | BUY | $1,424 8 sh | Mar 13, 2026 traded Nov 18, 2022 |
| 41 | Jackson Jeremy PeterDirector, Chief Executive Officer | Open-market sale | SELL | $467K 4,326 sh | Mar 13, 2026 traded Mar 11, 2026 |
| 41 | Howe AmyCEO & President - FanDuel | Open-market sale | SELL | $799K 7,551 sh | Mar 13, 2026 traded Mar 11, 2026 |
| 41 | McKinney Scott T.Chief Financial Officer | Open-market purchase | BUY | $42K 2,600 sh | Mar 13, 2026 traded Mar 11, 2026 |
| 41 | Doka Celina J. WangDirector | Open-market purchase | BUY | $100K 4,760 sh | Mar 13, 2026 traded Mar 13, 2026 |
| 40 | Frazier SpencerEVP of Sales and Marketing | Open-market purchase | BUY | $212 1 sh | Mar 13, 2026 traded Aug 18, 2023 |
| 40 | Frazier SpencerEVP of Sales and Marketing | Open-market purchase | BUY | $211 1 sh | Mar 13, 2026 traded Feb 24, 2023 |
| 40 | Frazier SpencerEVP of Sales and Marketing | Open-market purchase | BUY | $1,292 8 sh | Mar 13, 2026 traded May 26, 2023 |
| 40 | Frazier SpencerEVP of Sales and Marketing | Open-market purchase | BUY | $622 3 sh | Mar 13, 2026 traded Jan 25, 2023 |
| 40 | Frazier SpencerEVP of Sales and Marketing | Open-market purchase | BUY | $1,084 6 sh | Mar 13, 2026 traded Aug 18, 2023 |
| 40 | Frazier SpencerEVP of Sales and Marketing | Open-market purchase | BUY | $1,082 6 sh | Mar 13, 2026 traded Feb 24, 2023 |
| 38 | Gonzalez Hugo EPres Powersports & Housing/COO | Open-market sale | SELL | $1.53M 13.5K sh | Mar 13, 2026 traded Mar 12, 2026 |